Dakota Johnson headlines as the title character in Madame Web, Sony’s fourth feature in their Spider-Man Universe on February 14th. The studio is hoping its grosses are closer to Venom and its sequel than Morbius. S.J. Clarkson directs with a supporting cast including Sydney Sweeney (hot off Anyone but You), Celeste O’Connor, Isabela Merced, and Tahar Rahim.
Ms. Johnson is no stranger to the Valentine’s Day/President’s Day weekend frame considering the Fifty Shades trilogy. Web will attempt to bring in a female contingent, but also a sizable male crowd craving some comic book action.
Debuting on Wednesday, my forecast includes the Friday to Monday long weekend projection along with its two extra days. A best case scenario might be in the $35-40 million neighborhood for the six-day total. I’m skeptical it gets that high. A low to mid 20s start for the four-day and high 20s to low 30s range over the longer haul sounds likelier.
Madame Web opening weekend prediction: $21.5 million (Friday to Monday); $30.7 million (Wednesday to Monday)
For my Bob Marley: One Love prediction, click here:
As we do every year on this here blog, Oscar nominations lead to my Case Of series. What are they? Glad you asked. These are 35 posts covering the nominees for Picture, Director, and the four acting contests. For each one, I give you the case for the movie/director/actor winning and the case against it with a verdict tidying it up. It’s like a trial, but no one goes to prison.
It began with the ten BP contenders and now it alternates alphabetically between the hopefuls in the five other big races. Today we arrive at the Supporting Actress quintet and it starts with Emily Blunt in Oppenheimer. Let’s get to it!
Previous Oscar Acting Nominations:
None
The Case for Emily Blunt:
Despite an impressive filmography covering dramas, action/adventure pics, family fare, and horror hits – from Sicario and Edge of Tomorrow to A Quiet Place to Mary Poppins Returns and Jungle Cruise – Blunt has somehow never nabbed an Oscar nod until now for the BP frontrunner. That’s despite her six Golden Globes noms for feature films and four SAG mentions. There could be an overdue vibe occurring and Oppenheimer‘s coattails could be large. As the alcoholic wife of the title character, she’s landed recognition in key precursors like the Globes, SAG, BAFTA, and Critics Choice.
The Case Against Emily Blunt:
The Globes and Critics Choice have gone with Da’Vine Joy Randolph in The Holdovers and she is certainly the favorite. A SAG or BAFTA victory win may be needed to show any strength. Voters may honor her costars Cillian Murphy and Robert Downey Jr. in their races and that might feel like enough.
The Verdict:
For quite some time, I had Danielle Brooks (The Color Purple) as the runner-up to Randolph. I’d say the spot belongs to Blunt now. However, nothing has happened yet to show that Randolph is vulnerable.
My Case Of Posts will continue with Sterling K. Brown in American Fiction…
As we do every year on this here blog, Oscar nominations lead to my Case Of series. What are they? Glad you asked. These are 35 posts covering the nominees for Picture, Director, and the four acting contests. For each one, I give you the case for the movie/director/actor winning and the case against it with a verdict tidying it up. It’s like a trial, but no one goes to prison.
It began with the ten BP contenders and now it alternates alphabetically between the hopefuls in the five other big races. Today we arrive at the Actor quintet and it starts with Bradley Cooper in Maestro. Let’s get to it!
Previous Oscar Acting Nominations:
Silver Linings Playbook (2012, Actor); American Hustle (2013, Supporting Actor); American Sniper (2014, Actor); A Star Is Born (2018, Actor)
The Case for Bradley Cooper:
For his portrayal of the legendary EGOT recipient Leonard Bernstein in the Netflix production, Mr. Cooper has been nominated for BAFTA, Critics Choice, SAG, and the Globes. There could also be the feeling that he’s overdue as this marks his fifth acting nod with no hardware to show for it (just like Annette Bening in Nyad per my previous post).
The Case Against Bradley Cooper:
He didn’t win the Globe or Critics Choice as Paul Giamatti (The Holdovers) and Cillian Murphy (Oppenheimer) have split the prizes so far. While Maestro had a decent nomination morning, Cooper was not recognized for his direction. That’s what happened in 2018 when he got the Actor mention for Star (he would lose to Rami Malek in Bohemian Rhapsody), but not his behind the camera work. Of all the BP contenders, this has the lowest RT rating and there’s a feeling among some that Cooper is trying too hard in Maestro for the gold.
The Verdict:
Cooper is third behind Murphy and Giamatti. I don’t think his victory is an impossibility. Yet it looks to be a long shot unless he scores an upset at SAG or BAFTA. In other words, the O in EGOT should still be unfulfilled.
My Case Of posts will continue with Emily Blunt in Oppenheimer…
Horror comedy Lisa Frankenstein looks to top the charts in what should be a sleepy box office frame. It’s the only new wide release hitting cineplexes and you can peruse my detailed prediction post on it here:
While I don’t have Frankenstein even achieving $10 million, my forecast is enough to put it in first position. Let’s be frank – Sunday should especially be a dead zone as many moviegoers will be preoccupied by the Chiefs and 49ers.
Argylle was ushered in as the champ this past frame (more on that below), but it underwhelmed. With a troubling C+ Cinemascore grade, I’m thinking a sophomore plummet in the range of 60% is possible.
The Chosen Season 4: Episodes 1-3 had a fruitful runner-up beginning. Yet it appears poised to drop from the high five considering its decline should be massive (probably in the 75-80% arena like its previous episodic releases).
That could leave holdovers The Beekeeper, Wonka, and Migration in their current 3-5 places. This is with a big caveat: Dune is scheduled to be re-released this weekend ahead of the sequel’s March bow and I’m waiting to see a count. I certainly believe it’s feasible that it manages a top 5 showing. Disney is also putting Turning Red back in venues. I’m less convinced it makes the five, but it’s doable. I will edit this post if I put either of them in (probably on Wednesday).
Here’s how I see it playing out:
1. Lisa Frankenstein
Predicted Gross: $6.8 million
2. Argylle
Predicted Gross: $6.1 million
3. The Beekeeper
Predicted Gross: $3.5 million
4. Wonka
Predicted Gross: $3.4 million
5. Migration
Predicted Gross: $3.2 million
Box Office Results (February 2-4)
As mentioned, Matthew Vaughn’s spy action comedy Argylle had a hollow victory at #1 with $17.4 million. That’s a tad under my $18.3 million call and not an impressive gross considering the reported king’s ransom of $200 million that Apple paid for the rights.
The Chosen Season 4: Episodes 1-3 had pleasing viewership with $5.9 million from Friday to Sunday – just ahead of my $5.4 million take. Counting its Thursday start, it has earned $7.3 million.
The Beekeeper was third in weekend #4 with $5.2 million (I went with $4.8 million) for $49 million total.
Wonka was fourth after 8 weeks with $4.6 million. My prediction? $4.6 million! The overall tally is $201 million.
Migration rounded out the top five at $4.1 million and I incorrectly had it on the outside looking in. The animated tale is up to $106 million after 7 weeks.
Mean Girls fell from 1st to 6th after three weeks atop the charts with $3.8 million compared to my $4.3 million projection. It has made $66 million.
As we do every year on this here blog, Oscar nominations lead to my Case Of series. What are they? Glad you asked. These are 35 posts covering the nominees for Picture, Director, and the four acting contests. For each one, I give you the case for the movie/director/actor winning and the case against it with a verdict tidying it up. It’s like a trial, but no one goes to prison.
It began with the ten BP contenders and now it alternates alphabetically between the hopefuls in the other five big races. Today we arrive at the Actress quintet and it starts with Annette Bening in Nyad. Let’s get to it!
Previous Oscar Acting Nominations:
The Grifters (1990, Supporting Actress); American Beauty (1999, Actress), Being Julia (2004, Actress), The Kids Are All Right (2010, Actress)
The Case for Annette Bening:
SAG and Globe nominations preceded this, but Bening’s potential ace in the hole could be the overdue factor. While costar Jodie Foster (up for Supporting Actress) is a two-time Oscar recipient, Bening is 0 for 4.
The Case Against Annette Bening:
She’s swimming upstream for the victory with Nyad. The picture itself is not an awards player beyond its two leads. Bening missed the cut at BAFTA and Critics Choice. Emma Stone (Poor Things) vs. Lily Gladstone (Killers of the Flower Moon) appears to be the showdown for the gold.
The Verdict:
The strong likelihood is Bening will be 0 for 5 come March 10th.
My Case Of posts will continue with our first write-up in Actor. That’s Bradley Cooper in Maestro…
Laura Chinn’s Suncoast premiered at Sundance, is out in limited fashion weekend, and hits Hulu this Friday. The coming-of-age drama stars Laura Linney, Nico Parker, and Woody Harrelson.
Distributed by Searchlight, the writer/director’s debut work failed to break out in Utah. The Rotten Tomatoes score is a so-so 68%. Despite some praise for Linney and Parker, I wouldn’t expect awards voters to shed light on this. My Oscar Prediction posts will continue…
As we do every year on this here blog, Oscar nominations lead to my Case Of series. What are they? Glad you asked. These are 35 posts covering the nominees for Picture, Director, and the four acting contests. For each one, I give you the case for the movie/director/actor winning and the case against it with a verdict tidying it up. It’s like a trial, but no one goes to prison.
It begins with the ten BP contenders and then alternates alphabetically between the hopefuls in the other five big races. I’ve already covered nine of the BP nominees and they are linked at the bottom. This category’s posts conclude with Jonathan Glazer’s The Zone of Interest. Write-ups for the others are on deck!
The Case for The Zone of Interest:
After acclaimed features including Birth and Under the Skin, Glazer enters the awards zone with Interest. The German historical drama managed five nominations including Director, Adapted Screenplay, International Feature Film, and Sound. It’s had an impressive run at precursor nominations including the Globes in Drama and the PGA ten.
The Case Against The Zone of Interest:
Anatomy of a Fall has outshined it in victories with foreign races, including at the Globes and Critics Choice. It was definitely a question mark whether this would even make the cut at BP.
The Verdict:
Due to France choosing to submit The Taste of Things instead of Anatomy, Interest is the heavy favorite to take International Feature Film. That should be the only statue it picks up during the ceremony.
My Case Of posts will continue with Annette Bening in Nyad…
When the surprise is revealed at the end of David Fincher’s The Game, Michael Douglas’s character is reminded that he was drugged and left for dead in Mexico and all that he got was a lousy t-shirt (and a gigantic bill I might add). John Kramer aka Jigsaw (Tobin Bell) can relate in Saw X. And while he doesn’t get a t-shirt, he definitely gets some new games to engineer after his visit to our southern neighbor.
As many franchises do nowadays, this tenth installment of the nearly two decade old series doesn’t require knowledge of the entire canon. You really only need to remember Saw (2004) and its 2005 sequel (they remain the best two of the bunch). To jar those memories, Bell’s Kramer has terminal brain cancer. His civil engineering background allows him to concoct elaborate traps for victims. He doesn’t look at them that way because they’re generally terrible people who’ve wronged him or others. The patient known as Jigsaw doesn’t actually kill them as he gives them opportunities for escape and I suppose personal growth. As we’ve witnessed in nine pictures already, these candidates for redemption frequently fail their tests. One of Jigsaw’s would-be cases is Amanda (Shawnee Smith). She passed her exam back in the original and was revealed to be his apprentice in part II.
With those friendly reminders, Saw X takes place between the happenings of Saw and Saw II. John is freshly diagnosed and given months to live. An acquaintance from a cancer support group tips him to experimental therapy in Mexico run by Norwegian doctor Cecelia Pederson (Synnøve Macody Lund). The eventual surgery yields puzzling results and Jigsaw realizes that the Scandinavian surgeon and her conspirators need his unique form of tutelage. Let the games begin.
Among the flaws of many Saw entries after the second and third ones is they fell all over themselves trying to feature Bell’s Jigsaw in them (or at least his aura). Two of them (Saw VI, Saw 3D) were directed by Kevin Greutert and he returns here. I can understand the strained Jigsaw inclusions as he’s the most compelling character and other villains (or sadistic heroes depending on how you look at it) didn’t match up. Therefore it’s a relief that screenwriters Josh Stolberg and Peter Goldfinger (who penned the inferior immediate predecessor Spiral) find a clever way to make him the star. These movies are dimly lit so the fact that Bell and Smith have aged a few years isn’t much of a distraction. The script also gives Bell the most screen time he’s probably ever had. That’s a plus. Yet Saw X is also quite leisurely paced at two hours. Stretching a Saw saga beyond 90 to 100 minutes is a test of endurance.
Stolberg and Goldfinger were also responsible for Jigsaw in 2017. I found it to be a mostly effective reboot. Saw X is similar in quality. Like Jigsaw, it ebbs somewhat in the third act. It takes a little too long to get where it’s going. We know John and Amanda will set their barbarous traps and that’s delivered occasionally in peak Saw fashion. The straightforward story is far less convoluted than other sequels with their overreliance on flashbacks to bring Bell into the proceedings.
Bell is front and center in this for good reason. He’s got loads of intestinal fortitude to carry forth his mission. So do his captors at one point… you’ll see. This is the tenth pic arriving 19 years after we first met the patient. It belongs in the top half in the rankings and I would diagnose it as a cut above everything after the third one (with the possible exception of Jigsaw).
As we do every year on this here blog, Oscar nominations lead to my Case Of series. What are they? Glad you asked. These are 35 posts covering the nominees for Picture, Director, and the four acting contests. For each one, I give you the case for the movie/director/actor winning and the case against it with a verdict tidying it up. It’s like a trial, but no one goes to prison.
It begins with the ten BP contenders and then alternates alphabetically between the hopefuls in the other five big races. I’ve already covered eight of the BP nominees. They are linked at the bottom of the post. Next up is Poor Things from Yorgos Lanthimos.
The Case for Poor Things:
After The Favourite generated 10 nominations in 2018, Lanthimos’s follow-up bested that by 1 with 11. The multi-genre affair scored the second most nods overall for this year’s ceremony behind Oppenheimer‘s 13. The others are for the direction, Actress (Emma Stone), Supporting Actor (Mark Ruffalo), Adapted Screenplay, Cinematography, Costume Design, Film Editing, Makeup and Hairstyling, Original Score, and Production Design. Truth be told, it didn’t really miss anywhere (though Willem Dafoe was probably close to getting in for Supporting Actor alongside his costars). It’s been nominated for top honors at key precursors like BAFTA and Critics Choice and won Musical/Comedy (over Barbie) at the Globes.
The Case Against Poor Things:
Poor Things might be a little too out there for even the Academy. More importantly, you have to place it in at least second position (maybe third after The Holdovers) behind strong frontrunner Oppenheimer.
The Verdict:
Just as The Favourite wasn’t, this isn’t the favorite for BP. Like The Favourite and Olivia Colman, it might yield a Best Actress winner in Emma Stone and some tech victories. This might also go home empty-handed.
My Case Of posts will continue with The Zone of Interest…
At the Oscars honoring the movies of 2019, the Brits put up Chiwetel Ejiofor’s directorial debut The Boy Who Harnessed the Wind as their selection for International Feature Film. The Academy passed it up. At Sundance, the actor and filmmaker’s sophomore effort Rob Peace premiered. Based on a biography by Jeff Hobbs, the tragic drama stars Jay Will in the title role alongside Ejiofor as his father, Mary J. Blige, Camila Cabello, and Michael Kelly.
Various reviews are quite solid while some negative write-ups have emerged as well. The current result is a 75% RT rating (under Wind‘s 86%). Some reaction indicates this is a crowdpleaser and that could help with eventual awards prospects. However, the likelihood is that voters won’t give Peace a chance unless a distributor works serious magic. My Oscar Prediction posts will continue…